Walgreens Boots Alliance, Inc. (WBA) — 17.89 (-0.46)
Key Metrics & Ratings
- symbol WBA
- Rev/Share 165.0127
- Book/Share 31.9676
- PB 0.7063
- Debt/Equity 1.2229
- CurrentRatio 0.6642
- ROIC 0.0
- MktCap 19472450080.0
- FreeCF/Share -0.613
- PFCF -36.8099
- PE 81.8762
- Debt/Assets 0.3449
- DivYield 0.085
- ROE 0.0089
- Rating S-
- Score 5.0
- Recommendation Strong Buy
- P/E Score 5.0
- DCF Score 5.0
- P/B Score 5.0
- D/E Score 5.0
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | WBA | Leerink Partners | -- | Market Perform | -- | $23 | Feb. 26, 2024 |
| Downgrade | WBA | HSBC Securities | Hold | Reduce | -- | -- | Feb. 20, 2024 |
| Initiation | WBA | Barclays | -- | Underweight | -- | $21 | Jan. 3, 2024 |
| Initiation | WBA | HSBC Securities | -- | Hold | -- | $27 | Dec. 22, 2023 |
News
Walgreens launches own brand of opioid overdose reversal drug
Published: May 15, 2024 by: Reuters
Sentiment: Positive
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC).
Read More
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
Published: May 15, 2024 by: CNBC
Sentiment: Positive
Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than over-the-counter Narcan nasal spray.
Read More
Walgreens Boots Alliance (WBA) Outperforms Broader Market: What You Need to Know
Published: May 14, 2024 by: Zacks Investment Research
Sentiment: Positive
Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.
Read More
Why Walgreens Boots Alliance Stock Crushed the Market Today
Published: May 13, 2024 by: The Motley Fool
Sentiment: Positive
A media report stated that the pharmacy-chain operator is in talks to sell a core asset. At one point, that business unit apparently could have fetched nearly $9 billion.
Read More
Walgreens Stock Jumps on Report It's Looking To Boot Boots
Published: May 13, 2024 by: Investopedia
Sentiment: Positive
Walgreens Boots Alliance (WBA) shares jumped in intraday trading Monday following a report that the big drugstore chain has been reaching out to potential buyers of its British-based Boots unit.
Read More
Walgreens Stock Is Having Its Best Day in 4 Years. This Is Why.
Published: May 13, 2024 by: Barrons
Sentiment: Positive
The pharmacy giant is reaching out to possible buyers of its Boots drugstore chain in the United Kingdom, according to a report.
Read More
Walgreens seeks out potential buyers for sale of its UK Boots pharmacy chain, Bloomberg reports
Published: May 13, 2024 by: Reuters
Sentiment: Positive
Walgreens Boots Alliance is contacting potential buyers considering a potential sale of its UK-based Boots drugstore chain in a second attempt at separating the unit, Bloomberg News reported on Monday, sending shares up 7%.
Read More
Walgreens Boots seeks buyers for UK chemist chain as IPO plan evolves
Published: May 13, 2024 by: Proactive Investors
Sentiment: Positive
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) shares are up 6.6% on a report that the US group is talking to potential buyers of its Boots arm. Advisers have been hired and potential buyers are being sounded out over the £7 billion UK chemist chain, according to a Bloomberg report.
Read More
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
Published: May 07, 2024 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Walgreens (WBA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: May 07, 2024 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
3 Consumer Staples Stocks to Sell in May Before They Crash & Burn
Published: May 07, 2024 by: InvestorPlace
Sentiment: Negative
If you're wondering which consumer staples stocks to sell this month, look no further. The consumer is hanging tough.
Read More
3 Stocks Perfectly Positioned to Weather Market Swings in May
Published: May 06, 2024 by: InvestorPlace
Sentiment: Positive
May has historically been a month of market uncertainty on Wall Street, often characterized by the adage “Sell in May and go away.” While this strategy might not always hold true, it highlights the potential for increased volatility.
Read More
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
Published: April 15, 2024 by: The Motley Fool
Sentiment: Negative
Walgreens is still reeling from years of mismanagement. Gilead Sciences looks reliable, but is growing slowly.
Read More
Underestimated Giants: 7 Stocks Set to Take Wall Street by Storm
Published: April 12, 2024 by: InvestorPlace
Sentiment: Positive
If you're on the hunt for overlooked stocks to buy, look no further. Below is a carefully chosen list of seven underappreciated treasures, all full of unrealized potential and ready to cause a stir on Wall Street.
Read More
This Is How Walgreens' New CEO Thinks the Company Can Beat Amazon
Published: April 10, 2024 by: The Motley Fool
Sentiment: Positive
Walgreens has invested billions into primary care in recent years. The company is offering in-person assistance and guidance to patients.
Read More
5 Stocks to Buy as Interest Rates Begin to Fall
Published: April 09, 2024 by: InvestorPlace
Sentiment: Positive
In February, JPMorgan Chase (NYSE: JPM ) CEO Jamie Dimon unloaded $150 million of his company's stock – his first-ever sale. Shares of the bank had risen 70% since 2022, and valuations were beginning to look rich.
Read More
Insiders Are Buying These 5 Stocks
Published: April 04, 2024 by: Zacks Investment Research
Sentiment: Positive
Many investors closely monitor insider buys, as they can provide meaningful insight into the longer-term picture of a company. And recently, they've been deploying cash for these five stocks.
Read More
Is Walgreens Boots Alliance Stock Going to $35? 1 Wall Street Analyst Thinks So.
Published: April 04, 2024 by: The Motley Fool
Sentiment: Positive
To hit that price, the shares would have to rise by nearly 90%. The analyst feels the pharmacy chain operator is extremely undervalued.
Read More
The 3 Best Bargain Stocks to Buy in April 2024
Published: April 03, 2024 by: InvestorPlace
Sentiment: Positive
Momentum has been driving the market, led by artificial intelligence stocks, with the S&P 500 up 10% for the first quarter. However, the markets have started broadening, with financials, industrials and energy stocks also rallying.
Read More
Walgreens Boots Alliance Stock Has 87% Upside, According to 1 Wall Street Analyst
Published: April 03, 2024 by: The Motley Fool
Sentiment: Positive
Walgreens stock trades for less than 6 times forward earnings. The company recently narrowed its outlook for the year, and TD Cowen sees these targets as achievable.
Read More
2 Retail Pharmacy Stocks to Watch and One to Avoid Amid Industry Headwinds
Published: April 03, 2024 by: Zacks Investment Research
Sentiment: Positive
Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of economic challenges.
Read More
Should You Pick Walgreens Stock At $20?
Published: April 03, 2024 by: Forbes
Sentiment: Positive
Walgreens recently reported its Q2'24 results (fiscal ends in August), with revenue and earnings exceeding the street expectations. The company reported revenue of $37.1 billion and adjusted earnings of $1.20 per share, compared to the consensus estimates of $35.9 billion, and $0.82, respectively.
Read More
The Bargain Hunter's Dream: 3 Underpriced Stocks Poised for Massive Gains
Published: April 01, 2024 by: InvestorPlace
Sentiment: Positive
Three well-known companies stand out among the market's complexity as excellent opportunities for investors looking for significant gains. Each company operates in the broad domains of pharmaceuticals and healthcare, positioning it strategically to take advantage of new trends and consumer needs.
Read More
1 Reason to Buy Walgreens, 1 Reason to Sell, and a Better High-Yield Stock to Buy Either Way
Published: April 01, 2024 by: The Motley Fool
Sentiment: Negative
A new CEO is moving fast to get things in order. But those actions have yet to turn the cash flows challenges around.
Read More
Walgreens should scale back clinics to improve outlook, Jefferies analyst says
Published: March 31, 2024 by: Yahoo Finance
Sentiment: Negative
Walgreens Boots Alliance (WBA) posted its second report, revealing a quarterly revenue that beat expectations but a narrow outlook for 2024, citing difficult conditions within the retail environment. Jefferies Healthcare Services Equity Researcher Brian Tanquilut joins Yahoo Finance to discuss Walgreens' performance for the quarter and how it can mount a turnaround.
Read More
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
Published: March 31, 2024 by: The Motley Fool
Sentiment: Positive
Healthcare expenses tend to rise year after year regardless of what's happening to the overall economy. Medtronic has a 46-year history of consecutive annual dividend raises.
Read More
Walgreens CEO: ‘we will beat Amazon'
Published: March 29, 2024 by: Invezz
Sentiment: Positive
Tim Wentworth – the chief executive of Walgreens Boots Alliance Inc (NASDAQ: WBA) says his company offers a customer experience that's “unmatched”. What sets $WBA apart from competition?
Read More
Walgreens Boots CEO: We will beat Amazon because of our 'human interface' for customers
Published: March 28, 2024 by: CNBC Television
Sentiment: Positive
Walgreens Boots Alliance CEO Tim Wentworth sits down with 'Mad Money' host Jim Cramer to discuss the company's plan to innovate, competition from Amazon and the retail shrink problem.
Read More
Walgreens Boots Alliance CEO Tim Wentworth goes one-on-one with Jim Cramer
Published: March 28, 2024 by: CNBC Television
Sentiment: Positive
Walgreens Boots Alliance CEO Tim Wentworth sits down with 'Mad Money' host Jim Cramer to discuss the company's plan to innovate, competition from Amazon and the retail shrink problem.
Read More
7 Blue-Chip Stocks to Buy at a 52-Week Low in March
Published: March 28, 2024 by: InvestorPlace
Sentiment: Positive
If you're searching for cheap blue-chip stocks to buy, look no further. Blue-chip stocks continue to lag the performance of growth stocks.
Read More
About Walgreens Boots Alliance, Inc. (WBA)
- IPO Date 1980-03-17
- Website https://www.walgreensbootsalliance.com
- Industry Medical - Pharmaceuticals
- CEO Mr. Timothy C. Wentworth
- Employees 330000